Considering the fundamental role of ezrin as a linker between the cytoplasmic membrane and cytoskeleton, its loss mainly in the acinar apical region could be responsible for altered the AQP5 trafficking and mislocalization observed in SS patients. The gene discussed is AQP5; the disease is synovial sarcoma.